Literature DB >> 2122175

Generation of capsule-deficient Neisseria meningitidis strains by homologous recombination.

M Frosch1, E Schultz, E Glenn-Calvo, T F Meyer.   

Abstract

Capsule-deficient mutants of Neisseria meningitidis serogroup B strain B1940 were constructed by allelic replacement using the plasmids pMF120 and pMF121, which contain the flanking regions of the gene locus for the biosynthesis pathway of the group B meningococcal capsular polysaccharide. Southern blot analysis of chromosomal DNA of the capsule-deficient meningococcal strains confirmed the generation of large deletions in the chromosomal cps gene complex. The same strategy proved useful in constructing meningococcal strains with capsular types A, C, W135, Y and Z.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122175     DOI: 10.1111/j.1365-2958.1990.tb00697.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  23 in total

1.  Identification, characterization, and variable expression of a naturally occurring inhibitor protein of IS1106 transposase in clinical isolates of Neisseria meningitidis.

Authors:  P Salvatore; C Pagliarulo; R Colicchio; P Zecca; G Cantalupo; M Tredici; A Lavitola; C Bucci; C B Bruni; P Alifano
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Three-dimensional structure of the Neisseria meningitidis secretin PilQ determined from negative-stain transmission electron microscopy.

Authors:  Richard F Collins; Robert C Ford; Ashraf Kitmitto; Ranveig O Olsen; Tone Tønjum; Jeremy P Derrick
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

3.  Viability of a capsule- and lipopolysaccharide-deficient mutant of Neisseria meningitidis.

Authors:  Martine P Bos; Jan Tommassen
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  The Neisseria meningitidis capsule is important for intracellular survival in human cells.

Authors:  Maria Rita Spinosa; Cinzia Progida; Adelfia Talà; Laura Cogli; Pietro Alifano; Cecilia Bucci
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

5.  Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerization.

Authors:  Adelfia Talà; Laura Cogli; Mario De Stefano; Marcella Cammarota; Maria Rita Spinosa; Cecilia Bucci; Pietro Alifano
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

6.  Virulence Traits of a Serogroup C Meningococcus and Isogenic cssA Mutant, Defective in Surface-Exposed Sialic Acid, in a Murine Model of Meningitis.

Authors:  Roberta Colicchio; Chiara Pagliuca; Susanna Ricci; Elena Scaglione; Denis Grandgirard; Ilias Masouris; Fabrizio Farina; Caterina Pagliarulo; Giuseppe Mantova; Laura Paragliola; Stephen L Leib; Uwe Koedel; Gianni Pozzi; Pietro Alifano; Paola Salvatore
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

7.  Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response.

Authors:  Afshin Zariri; Joep Beskers; Bas van de Waterbeemd; Hendrik Jan Hamstra; Tim H E Bindels; Elly van Riet; Jos P M van Putten; Peter van der Ley
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

8.  A functional two-partner secretion system contributes to adhesion of Neisseria meningitidis to epithelial cells.

Authors:  Corinna Schmitt; David Turner; Maria Boesl; Marion Abele; Matthias Frosch; Oliver Kurzai
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

9.  Oxidation of D-lactate and L-lactate by Neisseria meningitidis: purification and cloning of meningococcal D-lactate dehydrogenase.

Authors:  A L Erwin; E C Gotschlich
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

10.  Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response.

Authors:  V Weynants; P Denoël; N Devos; D Janssens; C Feron; K Goraj; P Momin; D Monnom; C Tans; A Vandercammen; F Wauters; Jan T Poolman
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.